Ventyx Biosciences Inc. held a virtual special meeting of stockholders on March 3, 2026. Stockholders approved the adoption of the merger agreement with Eli Lilly and Company and approved an advisory vote on merger-related payments to named executive officers; an adjournment proposal was not presented.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ventyx Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-088654), on March 03, 2026, and is solely responsible for the information contained therein.
Comments